Catalyst Pharmaceuticals, Inc.

GABELLI & Co INVESTMENT ADVISERS, INC. CPRX

Report date

6/30/2026

Quarter

2026 Q2

Filed

8/12/2026

Shares

159,003

Value ($000)

4,997

Weight

0.7%

2026 Q2 - 2026 Q2 (1 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2026 Q2	8/12/2026	4,997	0.7%	159,003	6/30/2026